Expert Interview
Understanding the recent FDA approval of AstraZeneca's Airsupra (albuterol/budesonide) the first and only rescue medication to reduce risk of asthma exacerbations in adults.
Ticker(s): AZNInstitution - Hannibal Clinic
- Specializes in Critical Care Medicine, Internal Medicine, Pulmonary Disease and Sleep Medicine.
- Manages treatment for ~2000 patients with severe asthma.
- Familiar with the literature and use of Airsupra
How does the approval of arisupra change the current treatment landscape?
Added By: max_adminHow does airsupra compare and contrast to other available medications?
Added By: max_adminOn a scale from 1 - 10 how would you rate your excitement regarding the FDA approval of airsupra?
Added By: max_adminDo you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
